Risk-based TB screening: A primary care approach to TB elimination – webinar recording

Responsive image

Thank you for your interest.
One of our specialists will be in contact with you soon.

First Name*

Last Name*

Email address *

Phone*

City*

State or Province*

Country*

Zip or Postal Code

Organization*

Job Profession*

What test do you most often use as part of your clinical assessment for diagnosis of LTBI?*

Interferon-gamma release assay (IGRA): QuantiFERON®-TB Gold (Plus)

Interferon-gamma release assay (IGRA): T-SPOT®.TB

Tuberculin Skin Test (TST) / Mantoux

How is most TB testing at your practice driven?

Patient / Form driven (e.g., from employment or school)

Risk factor driven

On average, how many TB tests does your practice perform a month?

I want to be the first to hear about offers and news from QIAGEN. *

I hereby give QIAGEN the consent to contact me via email and phone (subject to the contact information provided above) with further special offers, contests and product information.

BANT_Budget*

For SP creation / could be hidden field

BANT_Authority*

For SP creation / could be hidden field

BANT_Need*

For SP creation / could be hidden field

BANT_Time*

For SP creation / could be hidden field

Product Line Interest

Primary Campaign Source

For SP creation / could be hidden field

Specific Interest

Lead Source - Most Recent*

For SP creation / could be hidden field

Interaction Request*

For SP creation / could be hidden field

Opportunity Type*

For SP creation / could be hidden field

Buying Type

If Opp Type is INSTRUMENT // For SP creation / could be hidden field

Instrument Type

If Opp Type is INSTRUMENT // For SP creation / could be hidden field

Risk-based TB screening: A primary care approach to TB elimination – webinar recording

We invite you to view a free webinar recording describing how primary care providers – particularly those working in public and community health centers – can lead the US effort to eliminate tuberculosis by implementing a comprehensive, risk-based TB screening program. You'll learn more about the most recent recommendations on TB testing and how IGRA-based screening programs can support TB elimination efforts while increasing efficiencies at the practice level.

QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. QFT-Plus Package Inserts as well as up-to- date licensing information and product-specific disclaimers can be found at www.QuantiFERON.com.

+ Subject to your consent given above, QIAGEN may use your personal information for internal business and marketing purposes. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) solely for the purposes of data hosting and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws, including the EU General Data Protection Regulation. For further details, please refer to our Privacy Policy.